Sympatholytic Mechanisms for the Beneficial Cardiovascular Effects of SGLT2 Inhibitors: A Research Hypothesis for Dapagliflozin’s Effects in the Adrenal Gland

Heart failure (HF) remains the leading cause of morbidity and death in the western world, and new therapeutic modalities are urgently needed to improve the lifespan and quality of life of HF patients. The sodium-glucose co-transporter-2 (SGLT2) inhibitors, originally developed and mainly indicated f...

Descripción completa

Detalles Bibliográficos
Autores principales: Lymperopoulos, Anastasios, Borges, Jordana I., Cora, Natalie, Sizova, Anastasiya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Hypothesis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8305388/
https://www.ncbi.nlm.nih.gov/pubmed/34299304
http://dx.doi.org/10.3390/ijms22147684

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8305388/
https://www.ncbi.nlm.nih.gov/pubmed/34299304
http://dx.doi.org/10.3390/ijms22147684

Ejemplares similares